US6010613A
(en)
*
|
1995-12-08 |
2000-01-04 |
Cyto Pulse Sciences, Inc. |
Method of treating materials with pulsed electrical fields
|
EP0938674B1
(de)
|
1996-11-16 |
2005-06-01 |
NMI Naturwissenschaftliches und Medizinisches Institut an der Universität Tübingen in Reutlingen Stiftung Bürgerlichen Rechts |
Mikroelementenanordnung, verfahren zum kontaktieren von in einer flüssigen umgebung befindlichen zellen und verfahren zum herstellen einer mikroelementenanordnung
|
WO1999011771A1
(en)
*
|
1997-09-04 |
1999-03-11 |
Science Research Laboratory, Inc. |
Cell separation using electric fields
|
CA2320377C
(en)
|
1998-02-24 |
2008-07-08 |
Boston Scientific Limited |
High flow rate dialysis catheters and related methods
|
DE19827957C2
(de)
*
|
1998-05-27 |
2000-06-29 |
Micronas Intermetall Gmbh |
Verfahren und Vorrichtung zur Messung einer Zustandsgröße
|
DE19841337C1
(de)
|
1998-05-27 |
1999-09-23 |
Micronas Intermetall Gmbh |
Verfahren und Vorrichtung zur intrazellulären Manipulation einer biologischen Zelle
|
GB9812519D0
(en)
*
|
1998-06-10 |
1998-08-05 |
Immunoporation Ltd |
Treating cells
|
US6221665B1
(en)
|
1998-06-10 |
2001-04-24 |
University Of South Florida |
Electrofusion chamber
|
GB9812783D0
(en)
*
|
1998-06-12 |
1998-08-12 |
Cenes Ltd |
High throuoghput screen
|
AU5122499A
(en)
|
1998-07-27 |
2000-02-21 |
Genentech Inc. |
Improved transformation efficiency in phage display through modification of a coat protein
|
GB9908681D0
(en)
*
|
1999-04-16 |
1999-06-09 |
Central Research Lab Ltd |
Apparatus for, and method of, introducing a substance into an object
|
US7053063B2
(en)
*
|
1999-07-21 |
2006-05-30 |
The Regents Of The University Of California |
Controlled electroporation and mass transfer across cell membranes in tissue
|
US6403348B1
(en)
*
|
1999-07-21 |
2002-06-11 |
The Regents Of The University Of California |
Controlled electroporation and mass transfer across cell membranes
|
US6927049B2
(en)
*
|
1999-07-21 |
2005-08-09 |
The Regents Of The University Of California |
Cell viability detection using electrical measurements
|
US6387671B1
(en)
|
1999-07-21 |
2002-05-14 |
The Regents Of The University Of California |
Electrical impedance tomography to control electroporation
|
US6300108B1
(en)
*
|
1999-07-21 |
2001-10-09 |
The Regents Of The University Of California |
Controlled electroporation and mass transfer across cell membranes
|
DE60143838D1
(de)
*
|
2000-01-27 |
2011-02-24 |
Mollennium Lab Nisshin |
Molekültransferierende vorrichtung, zusatz für molekültransferierende vorrrichtung und molekül-transferierendes verfahren
|
US6892099B2
(en)
*
|
2001-02-08 |
2005-05-10 |
Minnesota Medical Physics, Llc |
Apparatus and method for reducing subcutaneous fat deposits, virtual face lift and body sculpturing by electroporation
|
US6795728B2
(en)
|
2001-08-17 |
2004-09-21 |
Minnesota Medical Physics, Llc |
Apparatus and method for reducing subcutaneous fat deposits by electroporation
|
US8251986B2
(en)
|
2000-08-17 |
2012-08-28 |
Angiodynamics, Inc. |
Method of destroying tissue cells by eletroporation
|
US6697670B2
(en)
|
2001-08-17 |
2004-02-24 |
Minnesota Medical Physics, Llc |
Apparatus and method for reducing subcutaneous fat deposits by electroporation with improved comfort of patients
|
USRE42016E1
(en)
|
2001-08-13 |
2010-12-28 |
Angiodynamics, Inc. |
Apparatus and method for the treatment of benign prostatic hyperplasia
|
US6994706B2
(en)
*
|
2001-08-13 |
2006-02-07 |
Minnesota Medical Physics, Llc |
Apparatus and method for treatment of benign prostatic hyperplasia
|
US7130697B2
(en)
*
|
2002-08-13 |
2006-10-31 |
Minnesota Medical Physics Llc |
Apparatus and method for the treatment of benign prostatic hyperplasia
|
JP4217618B2
(ja)
*
|
2001-08-31 |
2009-02-04 |
サイト パルス サイエンシズ、インコーポレイテッド |
細胞融合のためのノンリニアーな振幅の誘電泳動用波形
|
US6713292B2
(en)
*
|
2001-12-06 |
2004-03-30 |
Bio-Rad Laboratories, Inc. |
Electroporation cuvette insert for facilitating membrane-based fusion
|
DE10202094B4
(de)
|
2002-01-21 |
2006-09-28 |
Eppendorf Ag |
Verfahren und Vorrichtung zur Elektroporation biologischer Zellen
|
EP1476548B1
(de)
*
|
2002-02-22 |
2007-06-06 |
I.D.M. Immuno-Designed Molecules |
Verfahren zur elektrofusion von zellen
|
AU2003249595A1
(en)
*
|
2002-07-16 |
2004-02-02 |
National Institute Of Agrobiological Sciences |
Electroporation method including the use of depressurization/pressurization
|
EP2359689B1
(de)
|
2002-09-27 |
2015-08-26 |
The General Hospital Corporation |
Mikrofluid-Vorrichtung zur Zelltrennung, sowie Verwendung derselben
|
EP1565555A4
(de)
*
|
2002-09-30 |
2008-07-09 |
Maxcyte Inc |
Vorrichtung und verfahren zur strämungselektroporation
|
US20050171574A1
(en)
|
2003-12-24 |
2005-08-04 |
The Regents Of The University Of California |
Electroporation to interrupt blood flow
|
US8298222B2
(en)
*
|
2003-12-24 |
2012-10-30 |
The Regents Of The University Of California |
Electroporation to deliver chemotherapeutics and enhance tumor regression
|
JP4443278B2
(ja)
*
|
2004-03-26 |
2010-03-31 |
テルモ株式会社 |
拡張体付カテーテル
|
AU2005250369A1
(en)
*
|
2004-05-18 |
2005-12-15 |
Genentech, Inc. |
M13 virus major coat protein variants for C-terminal and BI-terminal display of a heterologous protein
|
JPWO2006098430A1
(ja)
*
|
2005-03-17 |
2008-08-28 |
富士フイルム株式会社 |
細胞内物質導入装置、細胞クランプ装置及び流路の形成方法
|
US20070196820A1
(en)
|
2005-04-05 |
2007-08-23 |
Ravi Kapur |
Devices and methods for enrichment and alteration of cells and other particles
|
US20060264752A1
(en)
*
|
2005-04-27 |
2006-11-23 |
The Regents Of The University Of California |
Electroporation controlled with real time imaging
|
EP1734111B1
(de)
|
2005-06-13 |
2020-06-24 |
Tosoh Corporation |
Zellfusionsvorrichtung und Verfahren zur Zellfusion unter Verwendung derselben
|
US8114070B2
(en)
*
|
2005-06-24 |
2012-02-14 |
Angiodynamics, Inc. |
Methods and systems for treating BPH using electroporation
|
US20060293731A1
(en)
*
|
2005-06-24 |
2006-12-28 |
Boris Rubinsky |
Methods and systems for treating tumors using electroporation
|
US20060293730A1
(en)
|
2005-06-24 |
2006-12-28 |
Boris Rubinsky |
Methods and systems for treating restenosis sites using electroporation
|
US20060293725A1
(en)
*
|
2005-06-24 |
2006-12-28 |
Boris Rubinsky |
Methods and systems for treating fatty tissue sites using electroporation
|
CA2613885C
(en)
*
|
2005-06-30 |
2014-05-06 |
Lg Electronics Inc. |
Method and apparatus for encoding and decoding an audio signal
|
US8921102B2
(en)
|
2005-07-29 |
2014-12-30 |
Gpb Scientific, Llc |
Devices and methods for enrichment and alteration of circulating tumor cells and other particles
|
US20070105206A1
(en)
*
|
2005-10-19 |
2007-05-10 |
Chang Lu |
Fluidic device
|
US20070156135A1
(en)
*
|
2006-01-03 |
2007-07-05 |
Boris Rubinsky |
System and methods for treating atrial fibrillation using electroporation
|
JP2010506657A
(ja)
|
2006-10-16 |
2010-03-04 |
ザ リージェンツ オブ ザ ユニバーシティ オブ カリフォルニア |
組織の不可逆的エレクトロポレーションに使用される、所定の導電率を有するゲル
|
US20080132884A1
(en)
*
|
2006-12-01 |
2008-06-05 |
Boris Rubinsky |
Systems for treating tissue sites using electroporation
|
CN101679942A
(zh)
|
2007-02-23 |
2010-03-24 |
先进细胞技术公司 |
重编程分化细胞和从重编程的细胞产生动物和胚胎干细胞的高效方法
|
WO2009121009A2
(en)
|
2008-03-27 |
2009-10-01 |
The Regents Of The University Of California |
Irreversible electroporation device for use in attenuating neointimal
|
US20100004623A1
(en)
*
|
2008-03-27 |
2010-01-07 |
Angiodynamics, Inc. |
Method for Treatment of Complications Associated with Arteriovenous Grafts and Fistulas Using Electroporation
|
US9198733B2
(en)
|
2008-04-29 |
2015-12-01 |
Virginia Tech Intellectual Properties, Inc. |
Treatment planning for electroporation-based therapies
|
US11254926B2
(en)
|
2008-04-29 |
2022-02-22 |
Virginia Tech Intellectual Properties, Inc. |
Devices and methods for high frequency electroporation
|
AU2009243079A1
(en)
|
2008-04-29 |
2009-11-05 |
Virginia Tech Intellectual Properties, Inc. |
Irreversible electroporation to create tissue scaffolds
|
US10272178B2
(en)
|
2008-04-29 |
2019-04-30 |
Virginia Tech Intellectual Properties Inc. |
Methods for blood-brain barrier disruption using electrical energy
|
US9867652B2
(en)
|
2008-04-29 |
2018-01-16 |
Virginia Tech Intellectual Properties, Inc. |
Irreversible electroporation using tissue vasculature to treat aberrant cell masses or create tissue scaffolds
|
US9283051B2
(en)
|
2008-04-29 |
2016-03-15 |
Virginia Tech Intellectual Properties, Inc. |
System and method for estimating a treatment volume for administering electrical-energy based therapies
|
US10702326B2
(en)
|
2011-07-15 |
2020-07-07 |
Virginia Tech Intellectual Properties, Inc. |
Device and method for electroporation based treatment of stenosis of a tubular body part
|
US10117707B2
(en)
|
2008-04-29 |
2018-11-06 |
Virginia Tech Intellectual Properties, Inc. |
System and method for estimating tissue heating of a target ablation zone for electrical-energy based therapies
|
US10238447B2
(en)
|
2008-04-29 |
2019-03-26 |
Virginia Tech Intellectual Properties, Inc. |
System and method for ablating a tissue site by electroporation with real-time monitoring of treatment progress
|
US10245098B2
(en)
|
2008-04-29 |
2019-04-02 |
Virginia Tech Intellectual Properties, Inc. |
Acute blood-brain barrier disruption using electrical energy based therapy
|
US8992517B2
(en)
|
2008-04-29 |
2015-03-31 |
Virginia Tech Intellectual Properties Inc. |
Irreversible electroporation to treat aberrant cell masses
|
US11272979B2
(en)
|
2008-04-29 |
2022-03-15 |
Virginia Tech Intellectual Properties, Inc. |
System and method for estimating tissue heating of a target ablation zone for electrical-energy based therapies
|
US20090281477A1
(en)
*
|
2008-05-09 |
2009-11-12 |
Angiodynamics, Inc. |
Electroporation device and method
|
US9173704B2
(en)
|
2008-06-20 |
2015-11-03 |
Angiodynamics, Inc. |
Device and method for the ablation of fibrin sheath formation on a venous catheter
|
WO2010008834A2
(en)
|
2008-06-23 |
2010-01-21 |
Angiodynamics, Inc. |
Treatment devices and methods
|
US20100152725A1
(en)
*
|
2008-12-12 |
2010-06-17 |
Angiodynamics, Inc. |
Method and system for tissue treatment utilizing irreversible electroporation and thermal track coagulation
|
WO2010085765A2
(en)
|
2009-01-23 |
2010-07-29 |
Moshe Meir H |
Therapeutic energy delivery device with rotational mechanism
|
US8231603B2
(en)
|
2009-02-10 |
2012-07-31 |
Angiodynamics, Inc. |
Irreversible electroporation and tissue regeneration
|
US11638603B2
(en)
|
2009-04-09 |
2023-05-02 |
Virginia Tech Intellectual Properties, Inc. |
Selective modulation of intracellular effects of cells using pulsed electric fields
|
US11382681B2
(en)
|
2009-04-09 |
2022-07-12 |
Virginia Tech Intellectual Properties, Inc. |
Device and methods for delivery of high frequency electrical pulses for non-thermal ablation
|
WO2010118387A1
(en)
|
2009-04-09 |
2010-10-14 |
Virginia Tech Intellectual Properties, Inc. |
Integration of very short electric pulses for minimally to noninvasive electroporation
|
USD630321S1
(en)
|
2009-05-08 |
2011-01-04 |
Angio Dynamics, Inc. |
Probe handle
|
WO2010138919A2
(en)
|
2009-05-28 |
2010-12-02 |
Angiodynamics, Inc. |
System and method for synchronizing energy delivery to the cardiac rhythm
|
US9895189B2
(en)
|
2009-06-19 |
2018-02-20 |
Angiodynamics, Inc. |
Methods of sterilization and treating infection using irreversible electroporation
|
US20110118732A1
(en)
|
2009-11-19 |
2011-05-19 |
The Regents Of The University Of California |
Controlled irreversible electroporation
|
US9816086B2
(en)
*
|
2010-07-06 |
2017-11-14 |
The Ohio State University |
Dose and location controlled drug/gene/particle delivery to individual cells by nanoelectroporation
|
WO2012051433A2
(en)
|
2010-10-13 |
2012-04-19 |
Angiodynamics, Inc. |
System and method for electrically ablating tissue of a patient
|
WO2012088149A2
(en)
|
2010-12-20 |
2012-06-28 |
Virginia Tech Intellectual Properties, Inc. |
High-frequency electroporation for cancer therapy
|
US9382510B2
(en)
|
2011-08-25 |
2016-07-05 |
Jian Chen |
Methods and devices for electroporation
|
US9078665B2
(en)
|
2011-09-28 |
2015-07-14 |
Angiodynamics, Inc. |
Multiple treatment zone ablation probe
|
US9414881B2
(en)
|
2012-02-08 |
2016-08-16 |
Angiodynamics, Inc. |
System and method for increasing a target zone for electrical ablation
|
US9888956B2
(en)
|
2013-01-22 |
2018-02-13 |
Angiodynamics, Inc. |
Integrated pump and generator device and method of use
|
US10166321B2
(en)
|
2014-01-09 |
2019-01-01 |
Angiodynamics, Inc. |
High-flow port and infusion needle systems
|
AU2015259303B2
(en)
|
2014-05-12 |
2021-10-28 |
Arena, Christopher B. |
Selective modulation of intracellular effects of cells using pulsed electric fields
|
EP3194581A4
(de)
|
2014-09-15 |
2018-04-25 |
Children's Medical Center Corporation |
Verfahren und zusammensetzungen zur erhöhung der somatischen zellkerntransfer(scnt)-effizienz durch entfernung der histon h3-lysin-trimethylierung
|
WO2016100325A1
(en)
|
2014-12-15 |
2016-06-23 |
Virginia Tech Intellectual Properties, Inc. |
Devices, systems, and methods for real-time monitoring of electrophysical effects during tissue treatment
|
US10660691B2
(en)
|
2015-10-07 |
2020-05-26 |
Angiodynamics, Inc. |
Multiple use subassembly with integrated fluid delivery system for use with single or dual-lumen peristaltic tubing
|
US11390840B2
(en)
*
|
2016-09-30 |
2022-07-19 |
University Of Florida Research Foundation, Inc. |
Systems and methods including porous membrane for low-voltage continuous cell electroporation
|
US10905492B2
(en)
|
2016-11-17 |
2021-02-02 |
Angiodynamics, Inc. |
Techniques for irreversible electroporation using a single-pole tine-style internal device communicating with an external surface electrode
|
US11043823B2
(en)
*
|
2017-04-06 |
2021-06-22 |
Tesla, Inc. |
System and method for facilitating conditioning and testing of rechargeable battery cells
|
WO2019103857A1
(en)
|
2017-11-22 |
2019-05-31 |
Iovance Biotherapeutics, Inc. |
Expansion of peripheral blood lymphocytes (pbls) from peripheral blood
|
MX2020004967A
(es)
|
2017-11-17 |
2020-08-27 |
Iovance Biotherapeutics Inc |
Expansion de linfocitos infiltrantes del tumor (til) de aspirados con aguja fina y biopsias por puncion.
|
US11607537B2
(en)
|
2017-12-05 |
2023-03-21 |
Virginia Tech Intellectual Properties, Inc. |
Method for treating neurological disorders, including tumors, with electroporation
|
US11311329B2
(en)
|
2018-03-13 |
2022-04-26 |
Virginia Tech Intellectual Properties, Inc. |
Treatment planning for immunotherapy based treatments using non-thermal ablation techniques
|
US11925405B2
(en)
|
2018-03-13 |
2024-03-12 |
Virginia Tech Intellectual Properties, Inc. |
Treatment planning system for immunotherapy enhancement via non-thermal ablation
|
MX2020011134A
(es)
|
2018-04-27 |
2020-11-11 |
Iovance Biotherapeutics Inc |
Proceso cerrado para expansion y edicion de genes de linfocitos infiltrantes de tumor y usos de los mismos en inmunoterapia.
|
IT201800006914A1
(it)
*
|
2018-07-04 |
2020-01-04 |
|
Dispositivo di caratterizzazione elettrica di costrutti cellulari
|
KR20210091212A
(ko)
|
2018-11-05 |
2021-07-21 |
이오반스 바이오테라퓨틱스, 인크. |
항-pd-1 항체에 불응성인 nsclc 환자의 치료
|
CN113272420A
(zh)
|
2018-11-05 |
2021-08-17 |
艾欧凡斯生物治疗公司 |
经改进的肿瘤反应性t细胞的选择
|
WO2020096927A1
(en)
|
2018-11-05 |
2020-05-14 |
Iovance Biotherapeutics, Inc. |
Expansion of tils utilizing akt pathway inhibitors
|
JOP20210094A1
(ar)
|
2018-11-05 |
2023-01-30 |
Iovance Biotherapeutics Inc |
عمليات لإنتاج الخلايا الليمفاوية للورم الارتشاحي واستخداماتها في العلاج المناعي
|
US20220193131A1
(en)
|
2018-12-19 |
2022-06-23 |
Iovance Biotherapeutics, Inc. |
Methods of Expanding Tumor Infiltrating Lymphocytes Using Engineered Cytokine Receptor Pairs and Uses Thereof
|
EP3931310A1
(de)
|
2019-03-01 |
2022-01-05 |
Iovance Biotherapeutics, Inc. |
Expansion von tumorinfiltrierenden lymphozyten aus hämatologischen tumoren und therapeutische verwendungen davon
|
US20220249559A1
(en)
|
2019-05-13 |
2022-08-11 |
Iovance Biotherapeutics, Inc. |
Methods and compositions for selecting tumor infiltrating lymphocytes and uses of the same in immunotherapy
|
US11950835B2
(en)
|
2019-06-28 |
2024-04-09 |
Virginia Tech Intellectual Properties, Inc. |
Cycled pulsing to mitigate thermal damage for multi-electrode irreversible electroporation therapy
|
CA3155727A1
(en)
|
2019-10-25 |
2021-04-29 |
Cecile Chartier-Courtaud |
Gene editing of tumor infiltrating lymphocytes and uses of same in immunotherapy
|
JP2023506734A
(ja)
|
2019-12-11 |
2023-02-20 |
アイオバンス バイオセラピューティクス,インコーポレイテッド |
腫瘍浸潤リンパ球(til)の産生のためのプロセス及びそれを使用する方法
|
JP2023523855A
(ja)
|
2020-05-04 |
2023-06-07 |
アイオバンス バイオセラピューティクス,インコーポレイテッド |
腫瘍浸潤リンパ球の製造方法及び免疫療法におけるその使用
|
WO2022076606A1
(en)
|
2020-10-06 |
2022-04-14 |
Iovance Biotherapeutics, Inc. |
Treatment of nsclc patients with tumor infiltrating lymphocyte therapies
|
JP2023546359A
(ja)
|
2020-10-06 |
2023-11-02 |
アイオバンス バイオセラピューティクス,インコーポレイテッド |
腫瘍浸潤リンパ球療法によるnsclc患者の治療
|
JP2024500403A
(ja)
|
2020-12-17 |
2024-01-09 |
アイオバンス バイオセラピューティクス,インコーポレイテッド |
腫瘍浸潤リンパ球によるがんの治療
|
AU2021401302A1
(en)
|
2020-12-17 |
2023-07-06 |
Iovance Biotherapeutics, Inc. |
Treatment with tumor infiltrating lymphocyte therapies in combination with ctla-4 and pd-1 inhibitors
|
CA3206549A1
(en)
|
2021-01-29 |
2022-08-04 |
Frederick G. Vogt |
Methods of making modified tumor infiltrating lymphocytes and their use in adoptive cell therapy
|
EP4308691A1
(de)
|
2021-03-19 |
2024-01-24 |
Iovance Biotherapeutics, Inc. |
Verfahren zur expansion von tumorinfiltrierenden lymphozyten (til) im zusammenhang mit der cd39/cd69-auswahl und gen-knockout in tils
|
AR125199A1
(es)
|
2021-03-23 |
2023-06-21 |
Iovance Biotherapeutics Inc |
Edición génica cish de linfocitos infiltrantes de tumores y usos de los mismos en inmunoterapia
|
WO2022225981A2
(en)
|
2021-04-19 |
2022-10-27 |
Iovance Biotherapeutics, Inc. |
Chimeric costimulatory receptors, chemokine receptors, and the use of same in cellular immunotherapies
|
WO2022245754A1
(en)
|
2021-05-17 |
2022-11-24 |
Iovance Biotherapeutics, Inc. |
Pd-1 gene-edited tumor infiltrating lymphocytes and uses of same in immunotherapy
|
WO2023004074A2
(en)
|
2021-07-22 |
2023-01-26 |
Iovance Biotherapeutics, Inc. |
Method for cryopreservation of solid tumor fragments
|
CA3226942A1
(en)
|
2021-07-28 |
2023-02-02 |
Iovance Biotherapeutics, Inc. |
Treatment of cancer patients with tumor infiltrating lymphocyte therapies in combination with kras inhibitors
|
TW202328439A
(zh)
|
2021-09-09 |
2023-07-16 |
美商艾歐凡斯生物治療公司 |
使用pd-1 talen基因減弱生成til產物之方法
|
TW202331735A
(zh)
|
2021-10-27 |
2023-08-01 |
美商艾歐凡斯生物治療公司 |
協調用於患者特異性免疫療法之細胞之製造的系統及方法
|
WO2023086803A1
(en)
|
2021-11-10 |
2023-05-19 |
Iovance Biotherapeutics, Inc. |
Methods of expansion treatment utilizing cd8 tumor infiltrating lymphocytes
|
WO2023147488A1
(en)
|
2022-01-28 |
2023-08-03 |
Iovance Biotherapeutics, Inc. |
Cytokine associated tumor infiltrating lymphocytes compositions and methods
|
WO2023196877A1
(en)
|
2022-04-06 |
2023-10-12 |
Iovance Biotherapeutics, Inc. |
Treatment of nsclc patients with tumor infiltrating lymphocyte therapies
|
WO2023201369A1
(en)
|
2022-04-15 |
2023-10-19 |
Iovance Biotherapeutics, Inc. |
Til expansion processes using specific cytokine combinations and/or akti treatment
|
WO2023220608A1
(en)
|
2022-05-10 |
2023-11-16 |
Iovance Biotherapeutics, Inc. |
Treatment of cancer patients with tumor infiltrating lymphocyte therapies in combination with an il-15r agonist
|
WO2024055017A1
(en)
|
2022-09-09 |
2024-03-14 |
Iovance Biotherapeutics, Inc. |
Processes for generating til products using pd-1/tigit talen double knockdown
|
WO2024055018A1
(en)
|
2022-09-09 |
2024-03-14 |
Iovance Biotherapeutics, Inc. |
Processes for generating til products using pd-1/tigit talen double knockdown
|